Most Recent

image: Week in Review: June 2–6

Week in Review: June 2–6

By | June 6, 2014

The malnourished microbiome; innate immunity and beige fat; tools for stem cell self-renewal; predicting tomorrow’s PIs; MERS update

0 Comments

image: Minimal Toolkit for Stem Cell Self-Renewal

Minimal Toolkit for Stem Cell Self-Renewal

By | June 5, 2014

Researchers identify a network of a dozen transcription factors needed to maintain the pluripotent state of mouse embryonic stem cells. 

0 Comments

image: Final Straw for STAP?

Final Straw for STAP?

By | June 4, 2014

Independent analysis uncovers suspected mouse cell mix-up, while stimulus-triggered acquisition of pluripotency lead author Haruko Obokata agrees to retract the work in full.

0 Comments

image: Beneficial Brew

Beneficial Brew

By | June 1, 2014

Drinking green tea appears to boost the activity of DNA repair enzymes.

0 Comments

image: Haley Oliver: Master of Meat

Haley Oliver: Master of Meat

By | June 1, 2014

Assistant Professor, Department of Food Science, Purdue University, Age: 32

0 Comments

image: Parsing Pathogens

Parsing Pathogens

By | June 1, 2014

Meet the peptide-covered microcantilever device capable of differentiating subtypes of Salmonella.

0 Comments

image: Week in Review: May 26–30

Week in Review: May 26–30

By | May 30, 2014

Human proteome cataloged; island-separated crickets evolved silence; molecule shows promise for combatting coronaviruses; study replication etiquette; another call for STAP retraction

0 Comments

image: Parsing the Penis Microbiome

Parsing the Penis Microbiome

By | May 29, 2014

Circumcision and sexual activity are but two factors that can influence the bacterial communities that inhabit male genitalia.

5 Comments

image: Spotlight on the Cytoskeleton

Spotlight on the Cytoskeleton

By | May 27, 2014

Technique allows researchers to see the inner workings of cellular scaffolding molecules actin and tubulin.

0 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS